The Drug Enforcement Administration (DEA) has received an application from Titan Health LLC to become registered to manufacture bulk quantities of marihuana for research purposes. This notice invites current registered bulk manufacturers and applicants to submit comments or objections by April 19, 2021. The DEA will review the application according to regulations to ensure compliance with legal requirements and prevent unlawful distribution. If approved, Titan Health LLC would be authorized to manufacture pharmaceuticals for research but not engage in other activities without additional approval.
Simple Explanation
The DEA is looking at an application from a company named Titan Health LLC that wants to make lots of a special plant called marihuana for researchers to study. This plan is just for scientists' work, and the DEA will carefully check things to ensure that Titan Health follows the rules.